Legal Help Still Available as Bayer Begins Settling Yaz Lawsuits

Share Article

The Yaz Resource Center contains more information on Yaz FDA warnings, side effects, litigation news and legal options. Find out more at YazLawsuitClaim.com

yaz lawsuit
More than 6,000 women have filed lawsuits alleging they were injured after taking Yaz or Yasmin, according to a federal Multi-District Litigation court established to handle the bulk of the cases in the Southern District of Illinois.

As a federal court tasked with handling thousands of lawsuits over Yaz side effects was set to begin trials, the maker of the popular drug has announced that it has started settling some of the outstanding lawsuits.

More than 6,000 women have filed lawsuits alleging they were injured after taking Yaz or Yasmin, according to a federal Multi-District Litigation court established to handle the bulk of the cases in the Southern District of Illinois.

Most of the lawsuits have been consolidated under the case Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100). However, as the first trials were set to begin last fall, Judge David Herndon postponed litigation indefinitely and urged the parties to attempt to settle the cases.

According to the annual report released by Bayer on February 13, 2012, the company has now settled at least 70 cases. No details or amounts of the settlements were given and the company has not admitted any fault. http://www.annualreport2011.bayer.com/en/bayer-annual-report-2011.pdfx.

According to the FDA, millions of women have taken Yaz or Yasmin since their first release in 2001. The agency has issued warnings about possible health concerns after receiving hundreds of reports of injury or death among users. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/ucm053993.pdf.

Researchers have linked the drugs to blood clots, which may cause strokes, deep vein thrombosis (DVT) and pulmonary embolisms.

In 2009, The British Medical Journal reported studies from Denmark and the Netherlands which found women taking oral contraceptives like Yaz had an increased risk of blood clots.

In October, 2011, the FDA released a study of more than 800,000 women taking oral contraceptives which showed that those taking drugs like Yaz had a 75% increased risk of developing blood clots. http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf.

In December, an FDA advisory panel recommended the label of Yaz be changed to warn of the health risks based on these studies.

For now, the federal Multi District Litigation case for claims of Yaz side effects remains open. Lawyers are still available to help those who have questions about their legal rights after taking the drug, however, they caution that time may be limited. This can be compared to a Yaz class action lawsuit for those not familiar with the MDL process.

For more information on FDA warnings and Yaz side effects, as well as news on current litigation and legal options for patients, visit YazLawsuitClaim.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Schroeder
Yaz Center
1-888-315-7458
Email >
Visit website